2-aminopurine has been researched along with Chronic Hepatitis C in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Córdoba Cortijo, J; López Viedma, B; Olaso Peiró, V | 1 |
| Main, J; McCarron, B; Thomas, HC | 1 |
| Airoldi, A; Pinzello, G; Zavaglia, C | 1 |
3 review(s) available for 2-aminopurine and Chronic Hepatitis C
| Article | Year |
|---|---|
[New antiviral agents in the treatment of chronic hepatitis B and C].
Topics: 2-Aminopurine; Antimetabolites; Antiviral Agents; Clinical Trials as Topic; Famciclovir; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Lamivudine; Prodrugs; Reverse Transcriptase Inhibitors; Ribavirin | 1998 |
Treatment of chronic viral hepatitis.
Topics: 2-Aminopurine; Animals; Antimetabolites; Antiviral Agents; Carcinoma, Hepatocellular; Disease Models, Animal; Drug Therapy, Combination; Ducks; Famciclovir; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatitis, Animal; Humans; Immunologic Factors; Interferon-alpha; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Marmota; Poultry Diseases; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Tumor Cells, Cultured | 1998 |
Antiviral therapy of HBV- and HCV-induced liver cirrhosis.
Topics: 2-Aminopurine; Antiviral Agents; Clinical Trials as Topic; Famciclovir; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon-alpha; Lamivudine; Liver Cirrhosis; Male; Prognosis; Reverse Transcriptase Inhibitors; Survival Rate; Thymalfasin; Thymosin; Treatment Outcome | 2000 |